SpectrumDNA Valuation
| SPXA Stock | USD 0.01 0.00 0.00% |
SpectrumDNA seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of SpectrumDNA from inspecting the company fundamentals such as Return On Equity of -13.03, current valuation of 237.12 K, and Price To Earning of (0.07) X as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting SpectrumDNA's valuation include:
Overvalued
Today
Please note that SpectrumDNA's price fluctuation is very steady at this time. Calculation of the real value of SpectrumDNA is based on 3 months time horizon. Increasing SpectrumDNA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since SpectrumDNA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SpectrumDNA Stock. However, SpectrumDNA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0098 | Real 0.008232 | Hype 0.0098 | Naive 0.0098 |
The real value of SpectrumDNA Stock, also known as its intrinsic value, is the underlying worth of SpectrumDNA Company, which is reflected in its stock price. It is based on SpectrumDNA's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of SpectrumDNA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of SpectrumDNA helps investors to forecast how SpectrumDNA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SpectrumDNA more accurately as focusing exclusively on SpectrumDNA's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use SpectrumDNA's intrinsic value based on its ongoing forecasts of SpectrumDNA's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against SpectrumDNA's closest peers. If more than one evaluation category is relevant for SpectrumDNA we suggest using both methods to arrive at a better estimate.
SpectrumDNA Cash |
|
SpectrumDNA Total Value Analysis
SpectrumDNA is at this time anticipated to have valuation of 237.12 K with market capitalization of 684.98 K, debt of 15.83 K, and cash on hands of 4.22 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the SpectrumDNA fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
237.12 K | 684.98 K | 15.83 K | 4.22 K |
SpectrumDNA Investor Information
The company recorded a loss per share of 0.04. SpectrumDNA had not issued any dividends in recent years. Based on the key measurements obtained from SpectrumDNA's financial statements, SpectrumDNA is not in a good financial situation at this time. It has a very high risk of going through financial distress in February.SpectrumDNA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. SpectrumDNA has an asset utilization ratio of 26.44 percent. This suggests that the Company is making $0.26 for each dollar of assets. An increasing asset utilization means that SpectrumDNA is more efficient with each dollar of assets it utilizes for everyday operations.SpectrumDNA Profitability Analysis
The company reported the previous year's revenue of 141.25 K. Net Loss for the year was (1.97 M) with profit before overhead, payroll, taxes, and interest of 137.17 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates SpectrumDNA's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in SpectrumDNA and how it compares across the competition.
About SpectrumDNA Valuation
The stock valuation mechanism determines SpectrumDNA's current worth on a weekly basis. Our valuation model uses a comparative analysis of SpectrumDNA. We calculate exposure to SpectrumDNA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SpectrumDNA's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 157.7 K | 165.6 K | |
| Pretax Profit Margin | (12.53) | (13.16) | |
| Operating Profit Margin | (12.26) | (12.87) | |
| Net Loss | (12.53) | (13.16) | |
| Gross Profit Margin | 0.87 | 0.92 |
SpectrumDNA Current Valuation Indicators
Valuation refers to the process of determining the present value of SpectrumDNA and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value SpectrumDNA we look at many different elements of the entity such as SpectrumDNA's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as SpectrumDNA, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use SpectrumDNA's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes SpectrumDNA's worth.Complementary Tools for SpectrumDNA Stock analysis
When running SpectrumDNA's price analysis, check to measure SpectrumDNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpectrumDNA is operating at the current time. Most of SpectrumDNA's value examination focuses on studying past and present price action to predict the probability of SpectrumDNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpectrumDNA's price. Additionally, you may evaluate how the addition of SpectrumDNA to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |